100 related articles for article (PubMed ID: 11368877)
1. Overexpression of kalpha1 tubulin mRNA in thyroid anaplastic carcinoma.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Cancer Lett; 2001 Jul; 168(1):51-5. PubMed ID: 11368877
[TBL] [Abstract][Full Text] [Related]
2. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Jpn J Clin Oncol; 2002 Jul; 32(7):229-32. PubMed ID: 12324571
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of catalase mRNA in thyroid anaplastic carcinoma.
Hasegawa Y; Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Jpn J Clin Oncol; 2003 Jan; 33(1):6-9. PubMed ID: 12604716
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles in thyroid carcinomas.
Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma.
Hasegawa Y; Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Cancer Lett; 2002 Aug; 182(1):69-74. PubMed ID: 12175525
[TBL] [Abstract][Full Text] [Related]
9. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.
Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N
Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503
[TBL] [Abstract][Full Text] [Related]
10. Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.
Takano T; Matsuzuka F; Miyauchi A; Yokozawa T; Liu G; Morita S; Kuma K; Amino N
Br J Cancer; 1998 Jul; 78(2):221-4. PubMed ID: 9683297
[TBL] [Abstract][Full Text] [Related]
11. Localization and expression of thyroid hormone receptors normal and neoplastic human thyroid.
Crescenzi A; Graziano MF; Carosa E; Papini E; Rucci N; Nardi F; Trimboli P; Calvanese A; Jannini EA; D'Armiento M
J Endocrinol Invest; 2003 Oct; 26(10):1008-12. PubMed ID: 14759075
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors.
Xu J; Filetti S; Hershman JM
Thyroid; 2008 May; 18(5):533-9. PubMed ID: 18399756
[TBL] [Abstract][Full Text] [Related]
13. Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas.
Takano T; Miyauchi A; Matsuzuka F; Kuma K; Amino N
J Clin Endocrinol Metab; 2000 Feb; 85(2):765-8. PubMed ID: 10690888
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of osteonectin mRNA in thyroid carcinomas.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Hayashi N; Nakamori S; Amino N
Endocr J; 2002 Aug; 49(4):511-6. PubMed ID: 12402984
[TBL] [Abstract][Full Text] [Related]
16. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
17. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
18. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
Feilchenfeldt J; Tötsch M; Sheu SY; Robert J; Spiliopoulos A; Frilling A; Schmid KW; Meier CA
Mod Pathol; 2003 Nov; 16(11):1117-23. PubMed ID: 14614051
[TBL] [Abstract][Full Text] [Related]
19. Screening of specific changes in mRNAs in thyroid tumors by sequence specific differential display: decreased expression of c-fos mRNA in papillary carcinoma.
Liu G; Takano T; Matsuzuka F; Higashiyama T; Kuma K; Amino N
Endocr J; 1999 Jun; 46(3):459-66. PubMed ID: 10504000
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.
Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS
Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
